Lv5
1460 积分 2024-03-16 加入
Single‐Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7⁺ Subset Linked to Antiviral Potential in Chronic HBV Infection
10天前
已完结
Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors
29天前
已完结
Tumor slice culture system for ex vivo immunotherapy studies
1个月前
已关闭
Higher BST2 Expression Promotes the Anti‐HBV Effect of IFN‐α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg‐Positive Chronic Hepatitis B Patients
2个月前
已完结
Endoplasmic Reticulum Stress Potentiates the Immunosuppressive Microenvironment in Hepatocellular Carcinoma by Promoting the Release of SNHG6-Enriched Small Extracellular Vesicles
2个月前
已完结
Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone
2个月前
已完结
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
2个月前
已完结
Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens
2个月前
已完结
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
2个月前
已完结
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference
2个月前
已完结
皖公网安备34019202002308
